News

28.01.2021

CELLVIE closes $5M Seed Round led by Kizoo Technology

Harvard spin-off CELLVIE closes $5M seed round in pursuit of a new treatment modality: therapeutic mitochondria transfer

News

10.07.2020

CELLVIE’s mitochondria treatment has been granted orphan-drug designation from the FDA

cellvie has been granted orphan-drug designation for the use of mitochondria in the prevention of ischemia-reperfusion injury during solid organ transplantation.